Financing ·
Twist Bioscience Corporation priced an upsized public offering of 3,125,000 shares of common stock at $96.00 per share…
TWSTTwist Bioscience Corp
Twist Bioscience Corporation priced an upsized public offering of 3,125,000 shares of common stock at $96.00 per share on August 4, 2026. The company granted underwriters a 30-day option to purchase up to an additional 468,750 shares, which was exercised in full the following day. Net proceeds from the offering are expected to be approximately $327.1 million after deducting underwriting discounts and estimated expenses. Funds will support research and development, manufacturing expansion, and working capital. Twist Bioscience Corporation operates in the biotechnology industry, providing customizable DNA synthesis solutions for diagnostics, therapeutics, and research markets.